Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000044631
JPRN-UMIN000044631Completed未知

Effect of fibrate to liver enzyme in the patients with dyslipidemia - Liver enzyme and fibrate at dyslipidemia

Iwate medical university0 sites297 target enrollmentStarted: June 24, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
297
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Complicated with malignancy Disagree with registration of the study

Investigators

Similar Trials

Recruiting
Not Applicable
Inhibitory effect of therapeutic medicine on liver disease progression in metabolic dysfunction-associated fatty liver disease patientmetabolic dysfunction-associated fatty liver disease
JPRN-UMIN000044364Department of Gastroenterology, Hokkaido University Hospital500
Completed
Phase 3
The effect of probiotics on changes in liver enzymes, lipid factors and ultrasound evidence in children and adolescents aged 10 to 18 years with non-alcoholic fatty liveron-alcoholic fatty liver disease.Non-alcoholic fatty liver diseaseDB92
IRCT20220314054279N1Kashan University of Medical Sciences60
Completed
Phase 2
The effect of hepatoheal tablet on non alcoholic fatty livernon alcoholic fatty liver.Nonalcoholic fatty liver disease (NAFLD)
IRCT2014042612438N6Barij Research Center of Medicinal Herbs90
Recruiting
Phase 3
The effect of probiotics consumption on liver functioCholangitis
IRCT20200628047940N3Shiraz University of Medical Sciences44
Completed
Not Applicable
Validation study on the effects on liver function and skin barrier function by intake of adlayHealthy Adults
JPRN-UMIN000041108Healthcare Systems Co., Ltd.70